The functional coding variant Asn107Ile of the neuropeptide S receptor gene (NPSR1) is associated with schizophrenia and modulates verbal memory and the acoustic startle response.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  International Journal of Neuropsychopharmacology

• Publication date

  2012-10-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1017/S1461145711001623PMID 22078257
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diagnostic and Statistical Manual of Mental Disorders

  2013cited by this paper
• Aversive imagery in panic disorder: agoraphobia severity, comorbidity, and defensive physiology.

  2011cited by this paper
• Neuropeptide S Enhances Memory During the Consolidation Phase and Interacts with Noradrenergic Systems in the Brain

  2011influential reference
• Stability of prepulse inhibition and habituation of the startle reflex in schizophrenia: a 6-year follow-up study of initially antipsychotic-naive, first-episode schizophrenia patients.

  2011cited by this paper
• Neuropeptide S receptor deficiency modulates spontaneous locomotor activity and the acoustic startle response.

  2011cited by this paper
• Neuropeptide S receptor gene — converging evidence for a role in panic disorder

  2011influential reference
• Intra-amygdala injections of neuropeptide S block fear-potentiated startle.

  2010influential reference
• Acoustic startle response in panic disorder.

  2010cited by this paper
• Neuropeptide S attenuates neuropathological, neurochemical and behavioral changes induced by the NMDA receptor antagonist MK-801.

  2010cited by this paper
• Behavioral phenotyping of neuropeptide S receptor knockout mice.

  2009cited by this paper
• Prepulse inhibition of the startle response with chronic schizophrenia: a replication study.

  2009cited by this paper
• The dopamine hypothesis of schizophrenia: version III--the final common pathway.

  2009cited by this paper
• Pharmacology of neuropeptide S in mice: therapeutic relevance to anxiety disorders

  2008influential reference
• Neuropeptide S: anatomy, pharmacology, genetics and physiological functions.

  2008influential reference
• Diagnostic and Statistical Manual of Mental Disorders

  2008cited by this paper
• S57.04 - Impaired sensorimotor gating of the acoustic startle response in the prodrome of schizophrenia

  2008cited by this paper
• Neuropeptide S is a stimulatory anxiolytic agent: a behavioural study in mice

  2008influential reference
• Neuropeptide S-mediated control of fear expression and extinction: role of intercalated GABAergic neurons in the amygdala

  2008cited by this paper
• Gender-specific association of a functional coding polymorphism in the Neuropeptide S receptor gene with panic disorder but not with schizophrenia or attention-deficit/hyperactivity disorder.

  2007influential reference
• Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research

  2007cited by this paper
• Structure-Function Relationships in the Neuropeptide S Receptor

  2006cited by this paper
• Attenuation of the prepulse inhibition of the acoustic startle response within and between sessions.

  2006influential reference
• Sensorimotor gating and habituation of the startle response in schizophrenic patients randomly treated with amisulpride or olanzapine.

  2006influential reference
• Covariation bias and its physiological correlates in panic disorder patients.

  2005cited by this paper
• Pharmacological Characterization of Human and Murine Neuropeptide S Receptor Variants

  2005cited by this paper
• Neuropeptide S and Its Receptor: A Newly Deorphanized G Protein–Coupled Receptor System

  2005cited by this paper
• Neuropeptide S: a new player in the modulation of arousal and anxiety.

  2005influential reference
• Neuropeptide S as a novel arousal promoting peptide transmitter

  2005cited by this paper
• Neuropeptide S: a neuropeptide promoting arousal and anxiolytic-like effects.

  2004influential reference
• Sensitization and habituation of the acoustic startle reflex in patients with schizophrenia.

  2004cited by this paper
• Maximum‐likelihood estimation of haplotype frequencies in nuclear families

  2004cited by this paper
• Animal behavior models of the mechanisms underlying antipsychotic atypicality.

  2003cited by this paper
• Impact of prepulse characteristics on the detection of sensorimotor gating deficits in schizophrenia.

  2001cited by this paper
• Smoking withdrawal, nicotine dependence and prepulse inhibition of the acoustic startle reflex

  1999cited by this paper
• Memory impairment in schizophrenia: a meta-analysis.

  1999influential reference
• Neurocognitive deficit in schizophrenia: a quantitative review of the evidence.

  1998influential reference
• Do Novel Antipsychotics Have Similar Pharmacological Characteristics? A Review of the Evidence

  1998cited by this paper
• Baseline and fear-potentiated startle in panic disorder patients.

  1994cited by this paper
• Gating and habituation of the startle reflex in schizophrenic patients.

  1992influential reference
• Performance measures of 16- to 86-year-old males and females on the auditory verbal learning test.

  1990cited by this paper
• Habituation of the Blink reflex in normals and schizophrenic patients.

  1982cited by this paper
• Antipsychotic drugs, neurotransmitters, and schizophrenia.

  1978cited by this paper

• An integrative neurogenomics workflow for precision medicine in neurodegenerative disorders.

  2026cites this paper
• Neuropeptide S receptor in GtoPdb v.2025.3

  2025cites this paper
• Screening and function analysis of key genes and signaling pathways in Alzheimer’s disease via next generation sequencing data analysis and bioinformatics approaches

  2025cites this paper
• Pathophysiological and Therapeutic Implications of Neuropeptide S System in Neurological Disorders.

  2024cites this paper
• The Influence of the Estrous Cycle on Neuropeptide S Receptor-Mediated Behaviors

  2024cites this paper
• Relationship of Neuropeptide S (NPS) with Neurocognitive, Clinical, and Electrophysiological Parameters of Patients during Structured Rehabilitation Therapy for Schizophrenia

  2022cites this paper
• Correlations between single nucleotide polymorphisms in obsessive-compulsive disorder with the clinical features or response to therapy.

  2022cites this paper
• Relationship of Neuropeptide S with Clinical and Metabolic Parameters of Patients during Rehabilitation Therapy for Schizophrenia

  2022cites this paper
• Pharmacology, Physiology and Genetics of the Neuropeptide S System

  2021cites this paper
• Neuropeptide S receptor in GtoPdb v.2021.3

  2021cites this paper
• Neandertal introgression and accumulation of hypomorphic mutations in the neuropeptide S (NPS) system promote attenuated functionality.

  2021cites this paper
• Neuropeptide S-Mediated Modulation of Prepulse Inhibition Depends on Age, Gender, Stimulus-Timing, and Attention

  2021cites this paper
• Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in Alzheimer’s disease

  2021cites this paper
• Genetic Determinants of Gating Functions: Do We Get Closer to Understanding Schizophrenia Etiopathogenesis?

  2020cites this paper
• The repertoire of family A-peptide GPCRs in archaic hominins.

  2019cites this paper
• Memory generalization after one‐trial contextual fear conditioning: Effects of sex and neuropeptide S receptor deficiency

  2019cites this paper
• Investigating the Contribution of NPSR1, IL-6 and BDNF Polymorphisms to Depressive and Anxiety Symptoms in Hemodialysis Patients.

  2019cites this paper
• Neuropeptide S receptor (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

  2019cites this paper
• The role of positive psychology in the treatment of overweight and obesity, and its effects on molecular genetic pathways involved

  2018cites this paper
• Association of NPSR1 rs324981 polymorphism and treatment response to antidepressants in Chinese Han population with generalized anxiety disorder.

  2018cites this paper
• Functional Polymorphisms in the Neuropeptide S Receptor are not associated with Juvenile Myoclonic Epilepsy

  2017cites this paper
• Sex-specific association between functional neuropeptide S receptor gene (NPSR1) variants and cortisol and central stress responses.

  2017cites this paper
• The Correlation-Base-Selection Algorithm for Diagnostic Schizophrenia Based on Blood-Based Gene Expression Signatures

  2017cites this paper
• Neuropeptide S precursor knockout mice display memory and arousal deficits

  2017cites this paper
• Long-term treatment with haloperidol affects neuropeptide S and NPSR mRNA levels in the rat brain

  2015cites this paper
• Neuroleptics Affect Neuropeptide S and NPSR mRNA Levels in the Rat Brain

  2015cites this paper
• Genetic Basis of a Cognitive Complexity Metric

  2015cites this paper
• Neuropeptide S Receptor Gene Variation Differentially Modulates Fronto‐Limbic Effective Connectivity in Childhood and Adolescence

  2015cites this paper
• Neuropeptide S and mental health: A functional receptor gene variant and environment shaping traits and contributing to psychiatric disorders

  2014cites this paper
• Neuronale Korrelate des Psychoserisikosyndroms

  2013cites this paper
• Eosinophil as a target for pathophysiological factors and pharmacological compounds

  2013cites this paper
• Neuropeptide S enhances memory and mitigates memory impairment induced by MK801, scopolamine or Aβ₁₋₄₂ in mice novel object and object location recognition tasks.

  2013cites this paper
• In vitro and in vivo pharmacological characterization of the novel neuropeptide S receptor ligands QA1 and PI1.

  2013cites this paper
• The functional coding variant Asn107Ile of the neuropeptide S receptor gene (NPSR1) influences age at onset of obsessive-compulsive disorder.

  2013cites this paper
• Studying individual differences and emotion regulation effects on PTSD-like responding and recovery : a psychophysiological VR-trauma paradigm

  2013cites this paper
• Characterization of Neuropeptide S (NPS) in view of its potential as a novel anxiolytic therapy for anxiety disorders

  2012cites this paper